These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1388645)

  • 1. Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal.
    Markou A; Koob GF
    Neuropsychopharmacology; 1992 Nov; 7(3):213-24. PubMed ID: 1388645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postcocaine anhedonia. An animal model of cocaine withdrawal.
    Markou A; Koob GF
    Neuropsychopharmacology; 1991 Jan; 4(1):17-26. PubMed ID: 2003866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmethylimipramine attenuates cocaine withdrawal in rats.
    Markou A; Hauger RL; Koob GF
    Psychopharmacology (Berl); 1992; 109(3):305-14. PubMed ID: 1365631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol lowers intracranial self-stimulation thresholds and enhances cocaine facilitation of intracranial self-stimulation in rats.
    Galankin T; Shekunova E; Zvartau E
    Horm Behav; 2010 Nov; 58(5):827-34. PubMed ID: 20736014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake.
    Holtz NA; Radke AK; Zlebnik NE; Harris AC; Carroll ME
    Brain Res; 2015 Mar; 1602():119-26. PubMed ID: 25582876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat.
    Slattery DA; Markou A; Froestl W; Cryan JF
    Neuropsychopharmacology; 2005 Nov; 30(11):2065-72. PubMed ID: 15841108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal from chronic cocaine administration induces deficits in brain reward function in C57BL/6J mice.
    Stoker AK; Markou A
    Behav Brain Res; 2011 Sep; 223(1):176-81. PubMed ID: 21557971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postcocaine depression and sensitization of brain-stimulation reward: analysis of reinforcement and performance effects.
    Kokkinidis L; McCarter BD
    Pharmacol Biochem Behav; 1990 Jul; 36(3):463-71. PubMed ID: 2377648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
    Jonkman S; Markou A
    Neurosci Lett; 2006 May; 400(1-2):140-5. PubMed ID: 16563623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of zif268 messenger RNA expression during prolonged withdrawal following "binge" cocaine self-administration in rats.
    Mutschler NH; Miczek KA; Hammer RP
    Neuroscience; 2000; 100(3):531-8. PubMed ID: 11098116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the anticonvulsant lacosamide compared to valproate and lamotrigine on cocaine-enhanced reward in rats.
    Béguin C; Potter DN; Carlezon WA; Stöhr T; Cohen BM
    Brain Res; 2012 Oct; 1479():44-51. PubMed ID: 22940183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The triple reuptake inhibitor DOV 216,303 induces long-lasting enhancement of brain reward activity as measured by intracranial self-stimulation in rats.
    Prins J; Kenny PJ; Doomernik I; Schreiber R; Olivier B; Mechiel Korte S
    Eur J Pharmacol; 2012 Oct; 693(1-3):51-6. PubMed ID: 23010469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oxytocin on nicotine withdrawal in rats.
    Manbeck KE; Shelley D; Schmidt CE; Harris AC
    Pharmacol Biochem Behav; 2014 Jan; 116():84-9. PubMed ID: 24239789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal following cocaine self-administration decreases regional cerebral metabolic rate in critical brain reward regions.
    Hammer RP; Pires WS; Markou A; Koob GF
    Synapse; 1993 May; 14(1):73-80. PubMed ID: 8511720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats.
    Chartoff E; Sawyer A; Rachlin A; Potter D; Pliakas A; Carlezon WA
    Neuropharmacology; 2012 Jan; 62(1):167-76. PubMed ID: 21736885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual approach to self-stimulation and locomotor trace affected by chronic methamphetamine treatment for an animal model of schizophrenia.
    Takigawa M; Maeda H; Ueyama K; Tominaga H; Matsumoto K
    Can J Physiol Pharmacol; 1993; 71(5-6):321-5. PubMed ID: 8402397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to cocaine in brain stimulation reward following continuous cocaine infusions.
    Pudiak CM; KuoLee R; Bozarth MA
    Pharmacol Biochem Behav; 2014 Jul; 122():246-52. PubMed ID: 24768900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe deficit in brain reward function associated with fentanyl withdrawal in rats.
    Bruijnzeel AW; Lewis B; Bajpai LK; Morey TE; Dennis DM; Gold M
    Biol Psychiatry; 2006 Mar; 59(5):477-80. PubMed ID: 16169528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine abstinence following chronic treatment alters cerebral metabolism in dopaminergic reward regions. Bromocriptine enhances recovery.
    Clow DW; Hammer RP
    Neuropsychopharmacology; 1991 Jan; 4(1):71-5. PubMed ID: 2003868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chronic cocaine on self-stimulation train-duration thresholds.
    Frank RA; Martz S; Pommering T
    Pharmacol Biochem Behav; 1988 Apr; 29(4):755-8. PubMed ID: 3413201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.